Autosomal erythropoietic protoporphyria

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Jul 2024Entire Papilla Preservation and Conventional Flap Surgery in Treating Intrabony Defects: A 6-Month Clinical Trial

Necmettin Erbakan University

TrialACTIVE NOT RECRUITING
Dec 2023INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP

Tanabe Pharma America, Inc. — PHASE3

TrialACTIVE NOT RECRUITING
Aug 2023HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

Disc Medicine, Inc — PHASE2, PHASE3

TrialENROLLING BY INVITATION
Aug 2021Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

Tanabe Pharma America, Inc. — PHASE3

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Autosomal erythropoietic protoporphyria.
Check the disease page for updates →

Clinical Trial Landscape

1 active trial
1PHASE2, PHASE3
1Total recruiting
Search clinical trials for Autosomal erythropoietic protoporphyria

Recent News & Research

No recent news articles indexed yet for Autosomal erythropoietic protoporphyria.
Search PubMed for Autosomal erythropoietic protoporphyria

Browse all Autosomal erythropoietic protoporphyria news →

Specialist Network

Top 6 by expertise

View all Autosomal erythropoietic protoporphyria specialists →

Quick Actions